Key result
Biscoclaurine alkaloids ameliorated white blood cell and platelet reduction, increased IFN-γ and VCAM-1 levels, and reduced oxidative stress and spleen injuries in mice exposed to 60Co-γ radiation.
Why the study?
Leukopenia is a common complication of chemoradiotherapy that damages hematopoietic, gastrointestinal, and immune systems and disrupts cancer treatment; the study investigated the protective effects of biscoclaurine alkaloids.
Does biscoclaurine alkaloids improve leukopenia in mice exposed to 60Co-γ radiation?
Does biscoclaurine alkaloids improve leukopenia in mice exposed to 60Co-γ radiation?
Biscoclaurine alkaloids demonstrate potential as a radioprotector and radiation mitigator by enhancing immune and hematopoietic functions and reducing oxidative stress in a mouse model of radiation-induced leukopenia.
BA may mitigate chemoradiotherapy-induced leukopenia in mice; leaves open clinical translation and requires human trials.
Objective. Leukopenia, a common complication of tumor chemoradiotherapy, contributes serious damage to the hematopoietic, gastrointestinal, and immune systems of the body and can cause delay, discontinuation, or even failure to tumor treatment, thereby greatly threatening human health. The present study aims to investigate the protective effects of biscoclaurine alkaloids (BA) on leukopenia. Methods. This study was conducted on 60 Kunming mice, which were randomly divided into six groups containing 10 animals each. A hematology analyzer was used to count white blood cells (WBC) in the peripheral blood cell. Mice serum was collected, and the granulocyte‐macrophage colony‐stimulating factor, vascular cell adhesion molecule 1 (VCAM‐1), and interferon‐γ (IFN‐γ) were detected by enzyme‐linked immunosorbent assays. Pathological changes were detected through hematoxylin and eosin staining in the liver and spleen of mice. The spleen and liver ultrastructures were observed via electron microscopy. Results. Results showed that BA ameliorated WBC, PLT reduction in the peripheral blood and significantly increased the levels of IFN‐γ and VCAM‐1 in mice serum. BA reduced ionizing radiation‐induced injuries to spleen, mitigated the reduction of superoxide dismutase (SOD), and significantly decreased the malonaldehyde (MDA) and xanthine oxidase (XOD) levels in the liver. Conclusion. BA enhanced the immune and hematopoietic functions and ameliorated the oxidative stress induced by 60Co‐γ radiation, revealing its therapeutic potential both as a radioprotector and as a radiation mitigator for leukopenia induced by 60Co‐γ radiation.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2020) studied Leukopenia induced by 60Co-γ radiation (n=60). Biscoclaurine alkaloids (BA) was evaluated on White blood cell and platelet counts, IFN-γ, VCAM-1, SOD, MDA, and XOD levels. Biscoclaurine alkaloids ameliorated white blood cell and platelet reduction, increased IFN-γ and VCAM-1 levels, and reduced oxidative stress and spleen injuries in mice exposed to 60Co-γ radiation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: